BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34148033)

  • 1. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.
    Zhang Y; Yang X; Zhu XL; Bai H; Wang ZZ; Zhang JJ; Hao CY; Duan HB
    Aging (Albany NY); 2021 Jun; 13(11):15459-15478. PubMed ID: 34148033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values and immune suppression of the S100A family in pancreatic cancer.
    Zhuang H; Chen X; Dong F; Zhang Z; Zhou Z; Ma Z; Huang S; Chen B; Zhang C; Hou B
    J Cell Mol Med; 2021 Mar; 25(6):3006-3018. PubMed ID: 33580614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue.
    Li J; Riau AK; Setiawan M; Mehta JS; Ti SE; Tong L; Tan DT; Beuerman RW
    Mol Vis; 2011; 17():2263-71. PubMed ID: 21897749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer: A STROBE study.
    Xu HY; Song HM; Zhou Q
    Medicine (Baltimore); 2020 Nov; 99(47):e22777. PubMed ID: 33217795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma.
    Zheng S; Liu L; Xue T; Jing C; Xu X; Wu Y; Wang M; Xie X; Zhang B
    Front Genet; 2021; 12():648156. PubMed ID: 33815482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrated Bioinformatic Analysis of the S100 Gene Family for the Prognosis of Colorectal Cancer.
    Zeng ML; Zhu XJ; Liu J; Shi PC; Kang YL; Lin Z; Cao YP
    Biomed Res Int; 2020; 2020():4746929. PubMed ID: 33294444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A proteins in the pathogenesis of experimental corneal neovascularization.
    Li C; Zhang F; Wang Y
    Mol Vis; 2010 Oct; 16():2225-35. PubMed ID: 21139687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100-mediated signal transduction in the nervous system and neurological diseases.
    Zimmer DB; Chaplin J; Baldwin A; Rast M
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):201-14. PubMed ID: 16171556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma.
    Li HB; Wang JL; Jin XD; Zhao L; Ye HL; Kuang YB; Ma Y; Jiang XY; Yu ZY
    BMC Cancer; 2021 Sep; 21(1):1039. PubMed ID: 34530774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values of S100 family members in ovarian cancer patients.
    Bai Y; Li LD; Li J; Lu X
    BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
    Su X; Li H; Chen S; Qin C
    Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of S100 family genes in patients with melanoma.
    Xiong TF; Pan FQ; Li D
    Melanoma Res; 2019 Feb; 29(1):23-29. PubMed ID: 30216200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
    Xu S; Tang L; Liu Z; Luo C; Cheng Q
    Front Immunol; 2021; 12():731048. PubMed ID: 34659218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New serum tumor markers S100, TFF3 and AIF-1 and their possible use in oncogynecology.
    Maděrka M; Pilka R; Neubert D; Hambálek J
    Ceska Gynekol; 2019; 84(4):303-308. PubMed ID: 31818115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study.
    Peterova E; Bures J; Moravkova P; Kohoutova D
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.